The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Although the introduction of highly active antiretroviral therapy (HAART) has led to a strong reduction of HIV-associated dementia (HAD) incidence, the prevalence of minor HIV-1-associated neurocognitive disorder (HAND) is rising among AIDS patients. HAART medication has shifted neuropathology from a subacute encephalitic condition to a subtle neurodegenerative process involving synaptic and dendritic degeneration, particularly of hippocampal neurons that are spared prior to HAART medication. Considerable neuroinflammation coupled with mononuclear phagocyte activation is present in HAART-medicated brains, particularly in the hippocampus. Accumulating evidence suggests that the resultant elevated secretion of pro-inflammatory cytokines such as interferon-γ, tumor necrosis factor-α, and interleukin-1β can increase amyloid-β peptide (Aβ) generation and reduce Aβ clearance. Recent advancements in Alzheimer’s disease (AD) research identified Aβ biogenesis and clearance venues that are potentially influenced by HIV viral infection, providing new insights into beta-amyloidosis segregation in HIV patients. Our study suggests enhanced beta-amyloidosis in ART-treated HAD and HIV-associated encephalitis brains and suppression of Aβ clearance by viral infection of human primary macrophages. A growing awareness of potential convergent mechanisms leading to neurodegeneration shared by HIV and Aβ points to a significant chance of comorbidity of AD and HAND in senile HIV patients, which calls for a need of basic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 2×
“Aβ production pathway The prevalent Aβ theory hypothesizes that the primary influence driving AD pathogenesis is the accumulation of Aβ in the brain, which is proposed to result from an imbalance between Aβ production and Aβ clearance (Hardy and Higgins 1992; Hardy and Selkoe 2002).”
BackgroundJohnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 2×
“ation with sheep reticulocytes (Johnstone et al. 1987) and had been observed in cells found in the CNS including macrophage, microglia, and neurons (Verani et al.”
BackgroundBrain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 7×
“However, there is also a conflicting report that CSF tau is not elevated in HAD subjects (Ellis et al. 1998; Green et al. 2005).”
BackgroundInfluentialSynaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715 · cited 1×
“…to neuroinflammation-mediated cell death, synaptic transmission, and synaptic plasticity (scaling) abnormalities implicated in AD (Albensi and Mattson 2000; Beattie et al. 2002; Volterra and Steinhauser 2004; Pickering et al. 2005; Stellwagen and Malenka 2006; Pickering and O'Connor 2007).”
BackgroundShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“…transport across vessel walls into the circulation mediated by blood vessel wall-expressed low-density lipoprotein receptor-related protein-1 (LRP-1; Shibata et al. 2000; Lam et al. 2001), clearance from brain via binding of Aβ to soluble LRP-1 circulating in blood (acting as an endogenous…”
BackgroundControl of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344 · cited 1×
“…to neuroinflammation-mediated cell death, synaptic transmission, and synaptic plasticity (scaling) abnormalities implicated in AD (Albensi and Mattson 2000; Beattie et al. 2002; Volterra and Steinhauser 2004; Pickering et al. 2005; Stellwagen and Malenka 2006; Pickering and O'Connor 2007).”
BackgroundMicroglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“IL-1β may also impair the microglia-mediated Aβ clearance (Hickman et al. 2008).”
BackgroundActivation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 3×
“It is a key mediator of inflammation and neuronal death in acute CNS injuries, such as stroke and brain trauma (Allan et al. 2005), and has been implicated in chronic neurodegenerative diseases such as AD and HAD (Griffin et al. 1989; Royston et al. 1992; Corasaniti et al. 2001; WyssCoray 2006).”
Background
Cited by
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Sierra, A., Abiega, O., Shahraz, A., & Neumann, H. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00006 · Cited by 574
Current understanding of HIV-associated neurocognitive disorders pathogenesis
Gannon, P., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 271
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern
The HIV Neurobehavioral Research Center (HNRC) Group, de Almeida, S. M., Ribeiro, C. E., Rotta, I., Letendre, S., Potter, M., Tang, B., Batistela, M., Vaida, F., & Ellis, R. J. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-019-00783-6 · Cited by 14
Metadata
- Authors
- Xu, J., & Ikezu, T.
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2008-11-19
- Volume
- 4
- Issue
- 2
- Pages
- 200-212
- ISSN
- 1557-1890 (ISSN-L)
- 1557-1904
- OpenAlex
- W1986063396
- Cited by
- 119
- References
- 37
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era. https://app.cochat.ai/papers/10.1007/s11481-008-9136-0
- The paper
- Xu, J., & Ikezu, T. (2009). The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-008-9136-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.